Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies

Nanoparticle-based therapies have been proposed in oncology research using various delivery methods to increase selectivity toward tumor tissues. Enhanced drug delivery through nanoparticle-based therapies could improve anti-tumor efficacy and also prevent drug resistance. However, there are still p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozzer, Sara, Dal Bo, Michele, Grimaldi, Maria Cristina, Toffoli, Giuseppe, Macor, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502742/
https://www.ncbi.nlm.nih.gov/pubmed/36145713
http://dx.doi.org/10.3390/pharmaceutics14091965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502742/
https://www.ncbi.nlm.nih.gov/pubmed/36145713
http://dx.doi.org/10.3390/pharmaceutics14091965

Ejemplares similares